Cargando…

Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration

IMPORTANCE: In 2013 and 2016, the US Food and Drug Administration (FDA) issued warnings and recommended limited use of fluoroquinolones for patients with certain acute conditions. It is not clear how prescribers have responded to these warnings. OBJECTIVE: To analyze changes in prescribing of fluoro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sankar, Ashwini, Swanson, Kristi M., Zhou, Jiani, Jena, Anupam Bapu, Ross, Joseph S., Shah, Nilay D., Karaca-Mandic, Pinar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637256/ https://www.ncbi.nlm.nih.gov/pubmed/34851398 http://dx.doi.org/10.1001/jamanetworkopen.2021.36662

Ejemplares similares

855. Impact of FDA Black Box Warning on Fluoroquinolone and Alternative Antibiotic Use in Southeastern US Hospitals
por: Yarrington, Michael, et al.
Publicado: (2018)

1863. Antibiotic Prescribing Before and After an FDA Boxed Warning on Fluoroquinolones in 2016
por: Willis, Zachary, et al.
Publicado: (2018)

Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims
por: Jena, Anupam B, et al.
Publicado: (2014)

Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial
por: Vu, Khoa, et al.
Publicado: (2021)

Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 2016
por: Jeffery, Molly M., et al.
Publicado: (2019)

Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified
por: Spielmans, Glen I., et al.
Publicado: (2020)

Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan
por: Abbas, Muhammad, et al.
Publicado: (2023)

Commentary: Duty to Warn: Antidepressant Black Box Suicidality Warning is Empirically Justified
por: Goodman, Wayne K., et al.
Publicado: (2020)

“Black box warning” rash with entecavir - case report
por: Cheong, Xiong Khee, et al.
Publicado: (2020)

Black Box Warning Did Not Cause Increased Suicides
por: Spielmans, Glen I., et al.
Publicado: (2021)

Response to “Black Box Warning Did Not Cause Increased Suicides”
por: Soumerai, Stephen B., et al.
Publicado: (2021)

Impact of safety warnings for fluoroquinolones on prescribing behaviour. Results of a cohort study with outpatient routine data
por: Georgi, Ulrike, et al.
Publicado: (2020)

Correction to: Impact of safety warnings for fluoroquinolones on prescribing behaviour. Results of a cohort study with outpatient routine data
por: Georgi, Ulrike, et al.
Publicado: (2021)

Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal Antibodies
por: Hagan, John B., et al.
Publicado: (2021)

Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a “Black Box” Warning: A Canadian Tertiary Care Center Study
por: Forbes, Nauzer, et al.
Publicado: (2016)

Challenging the FDA Black Box Warning for High Aspirin Dose With Ticagrelor in Patients With Diabetes
por: DiNicolantonio, James J., et al.
Publicado: (2013)

Black Box Warning: Cardiovascular Complications Make Motherhood Unsafe for African American Women
por: Lister, Rolanda, et al.
Publicado: (2020)

Patterns of Fluoroquinolone Prescribing at a Tuberculosis Hospital
por: Kizilbash, Quratulain, et al.
Publicado: (2017)

1008. The Reduction of Fluoroquinolone Prescribing in Rural Vermont Hospitals
por: Smith, Lindsay, et al.
Publicado: (2019)

Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage
por: Everhart, Alexander, et al.
Publicado: (2021)

The FDA “Black Box” Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?
por: Fornaro, Michele, et al.
Publicado: (2019)

Characteristics of Physicians Excluded From US Medicare and State Public Insurance Programs for Fraud, Health Crimes, or Unlawful Prescribing of Controlled Substances
por: Chen, Alice, et al.
Publicado: (2018)

The application of Box-Behnken-Design in the optimization of HPLC separation of fluoroquinolones
por: Czyrski, Andrzej, et al.
Publicado: (2019)

Assessment of Knowledge Regarding Safety Profile, Use, and Boxed Warnings of Fluoroquinolones Among Healthcare Professionals in Saudi Arabia: A Potential Implication for Drug Regulatory Authorities
por: Mallhi, Tauqeer Hussain, et al.
Publicado: (2022)

Evaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia
por: Kabbara, Wissam K, et al.
Publicado: (2015)

2092. Acceptability and Effectiveness of Implementation Strategies on Fluoroquinolone (FQ) Prescribing
por: Suda, Katie J, et al.
Publicado: (2019)

US Trends in COVID-19–Associated Hospitalization and Mortality Rates Before and After Reopening Economies
por: Gupta, Sumedha, et al.
Publicado: (2021)

Association of the US Food and Drug Administration Antipsychotic Drug Boxed Warning With Medication Use and Health Outcomes in Elderly Patients With Dementia
por: Rubino, Annalisa, et al.
Publicado: (2020)

Regional Rainfall Warning System for Landslides with Creep Deformation in Three Gorges using a Statistical Black Box Model
por: Guo, Zizheng, et al.
Publicado: (2019)

Impact of Fluoroquinolone Susceptibility Suppression on Discharge Prescribing for Acute Uncomplicated Cystitis
por: Hayden, Dillon A, et al.
Publicado: (2023)

Value of a cure for sickle cell disease in reducing economic disparities
por: Graf, Marlon, et al.
Publicado: (2022)

Unpacking the black box
por: Martins, Thiago Gonçalves dos Santos, et al.
Publicado: (2020)

The BOXES Methodology: Black Box Dynamic Control
por: Russell, David W
Publicado: (2012)

The Use of Social Media in Detecting Drug Safety–Related New Black Box Warnings, Labeling Changes, or Withdrawals: Scoping Review
por: Lee, Jae-Young, et al.
Publicado: (2021)

The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram
por: Friesen, Kevin J, et al.
Publicado: (2015)

Built Environment and Health Behaviors: Deconstructing the Black Box of Interactions—A Review of Reviews
por: Travert, Anne-Sophie, et al.
Publicado: (2019)

Decreased Outpatient Fluoroquinolone Prescribing Using a Multimodal Antimicrobial Stewardship Initiative
por: Lin, Kevin, et al.
Publicado: (2020)

70. Impact of Fluoroquinolone Susceptibility Suppression on Discharge Prescribing for Acute Uncomplicated Cystitis
por: Hayden, Dillon, et al.
Publicado: (2020)

20. Fluoroquinolone and Overall Outpatient Antibiotic Prescribing Trends in Adults, 2011 to 2018
por: Gouin, Katryna A, et al.
Publicado: (2020)

Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
por: McCoy, Rozalina G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cnitt8mhujt54s4p5k82k623g2